In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. - Rorick-Kehn, Linda M.; Johnson, Bryan G.; Knitowski, Karen M.; Salhoff, Craig R.; Witkin, Jeffrey M.; Perry, Kenneth W.; Griffey, Kelly I.; Tizzano, Joseph P.; Monn, James A.; McKinzie, David L.; Schoepp, Darryle D. (Psychopharmacology, 2007)